These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 647881)

  • 1. Decreased bioavailability of digoxin due to hypocholesterolemic interventions.
    Brown DD; Juhl RP; Warner SL
    Circulation; 1978 Jul; 58(1):164-72. PubMed ID: 647881
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of hypocholesterolemic interventions on digoxin bioavailability.
    Brown DD; Juhl RP; Warner SL
    Drug Metab Rev; 1979; 9(1):107-17. PubMed ID: 446263
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetic interactions between digoxin and other drugs.
    Marcus FI
    J Am Coll Cardiol; 1985 May; 5(5 Suppl A):82A-90A. PubMed ID: 2985676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of cholestyramine on the pharmacokinetics of cerivastatin.
    Mück W; Ritter W; Frey R; Wetzelsberger N; Lücker PW; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):250-4. PubMed ID: 9208341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cholestyramine on digoxin absorption and excretion in man.
    Hall WH; Shappell SD; Doherty JE
    Am J Cardiol; 1977 Feb; 39(2):213-6. PubMed ID: 835478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary excretion studies with digoxin in man.
    Klotz U; Antonin KH
    Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):332-4. PubMed ID: 892949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Digoxin: biological availability and interactions].
    Halwa B
    Wiad Lek; 1981 Jan; 34(1):31-4. PubMed ID: 7023063
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of bran and cholestyramine on plasma lipids in monkeys.
    Malinow MR; McLaughlin P; Papworth L; Naito HK; Lewis LA
    Am J Clin Nutr; 1976 Aug; 29(8):905-11. PubMed ID: 821335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Digoxin bioavailability under the effect of guar].
    Lembcke B; Häsler K; Kramer P; Caspary WF; Creutzfeldt W
    Beitr Infusionther Klin Ernahr; 1983; 12():48-54. PubMed ID: 6316916
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of cholestyramine on absorption of 3H digoxin in rats.
    Thompson WG
    Am J Dig Dis; 1973 Oct; 18(10):851-6. PubMed ID: 4742358
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of cholestyramine on thyroxine absorption.
    Northcutt RC; Stiel JN; Hollifield JW; Stant EG
    JAMA; 1969 Jun; 208(10):1857-61. PubMed ID: 5818830
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypocholesterolemic agents: a comparison of the relative effectiveness of cholestyramine and pectin in rats.
    Baig MM; Burgin CW; Cerda JJ
    Drug Nutr Interact; 1985; 3(2):109-13. PubMed ID: 3987520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vasoactive agents. 48].
    Richter J; Kny L; Gerecke K
    Pharm Prax; 1970; 12():265-6. PubMed ID: 5498747
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug treatment of hyperlipoproteinemia: bile acid-binding resins].
    Nakamura T; Matsuzawa Y
    Nihon Rinsho; 1994 Dec; 52(12):3266-70. PubMed ID: 7853721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pectin, a hypocholesterolemic polysaccharide, on vitamin A utilization in the rat.
    Phillips WE; Brien RL
    J Nutr; 1970 Mar; 100(3):289-92. PubMed ID: 5436218
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of hepatic 7 alpha-hydroxylase expression by dietary psyllium in the hamster.
    Horton JD; Cuthbert JA; Spady DK
    J Clin Invest; 1994 May; 93(5):2084-92. PubMed ID: 8182140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of cholestyramine on phenytoin bioavailability.
    Barzaghi N; Monteleone M; Amione C; Lecchini S; Perucca E; Frigo GM
    J Clin Pharmacol; 1988 Dec; 28(12):1112-4. PubMed ID: 3243928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cholesterol-lowering treatment on renal function.
    Liberopoulos EN; Mikhailidis DP; Athyros VG; Elisaf MS
    Am J Kidney Dis; 2006 Mar; 47(3):561; author reply 562. PubMed ID: 16490637
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship of in vitro binding of digoxin to its intestinal absorption in rats.
    Thompson WG
    Can J Physiol Pharmacol; 1973 Nov; 51(11):832-4. PubMed ID: 4762430
    [No Abstract]   [Full Text] [Related]  

  • 20. Congestive heart failure and toxic digoxin levels: role of cholestyramine.
    Roberge RJ; Sorensen T
    Vet Hum Toxicol; 2000 Jun; 42(3):172-3. PubMed ID: 10839325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.